Rep. Mary Felzkowski (R-Irma) and Sen. Kathy Bernier (R-Chippewa Falls) released a bill this morning that would create a medical cannabis program in Wisconsin. The bill, long in the drafting process, is the first Republican-sponsored medical marijuana bill introduced into the Wisconsin legislature since 2005. According to the Legislative Reference Bureau analyis of the bill, " Medical marijuana must be in the form of a liquid, oil, pill, or tincture or in a form that is applied topically."
Here is the press release: https://www.thewheelerreport.com/wheeler_docs/files/121119felzkowski.pdf
Republican Legislators Offer Avenue to Medical Marijuana Legalization
FOR IMMEDIATE RELEASE December 11, 2019
CONTACT: Rep. Mary Felzkowski 608-266-7694
Senator Kathy Bernier 608-266-7511
Madison- Representative Mary Felzkowski (R-Irma) and Senator Kathy Bernier (R-Chippewa Falls) released a bill Wednesday morning that would create a medical marijuana program in Wisconsin for patients with certain medical conditions:
The bill creates the framework for a program, managed by a newly created Medical Marijuana Regulatory Commission of legislative and gubernatorial appointees, that tightly regulates the cultivation, processing, testing, and dispensing of medical marijuana to ensure patients have legal, safe, and reliable access to a consistent product without breaking the law to obtain it.
Under the bill, patients with certain medical conditions would receive medical marijuana recommendations from participating medical professionals, gaining them access to a medical marijuana card through the Commission. Recent surveys show that a majority of WI citizens wish to have medical marijuana as a viable option for their health care needs. Felzkowski and Bernier believe now is the time to start the conversation.
"The 2018 referendums made it clear that Wisconsinites are asking the Legislature to really look at this issue," Rep. Felzkowski said. "Each one of us knows someone that has suffered through an illness. Medical marijuana is just another tool in the toolbox to help our suffering loved ones make it through the day with some semblance of normalcy." Senator Bernier continued: "With 33 other states leading the way on this, we can and must find a way to make this work in Wisconsin. The medical marijuana program our bill establishes is highly regulated while still creating access to the relief many Wisconsinites need as they deal with continuous pain."
This legislation is now available for lawmakers to sign on as co-sponsors to indicate support the bill. The authors hope to receive a public hearing in January of next year.
Representative Felzkowski represents the 35th Assembly District which includes portions of Langlade, Lincoln, Marathon, Oneida, and Shawano Counties.
Senator Bernier represents the 23rd Senate District which includes portions of Chippewa, Clark, Dunn, Eau Claire, Jackson, Marathon, Trempealeau, and Wood Counties.
Here is a draft of the bill: https://www.thewheelerreport.com/wheeler_docs/files/19lrb5095_01.pdf
Here is the analysis by the Legislative Reference Bureau
This bill creates a program that allows for the possession and use of medical marijuana by registered patients and that licenses medical marijuana producers, processors, dispensaries, transporters, and laboratories to operate in this state.
Medical Marijuana Regulatory Commission.
The bill creates the Medical Marijuana Regulatory Commission to regulate the medical marijuana program. The commission is attached to the Department of Revenue and consists of one member appointed by the governor, one member appointed by the senate majority leader, one member appointed by the speaker of the assembly, one member appointed by the senate minority leader, and one member appointed by the assembly minority leader. The members serve staggered terms of six years each. The governor selects one of the appointees to serve as the chairperson for a two-year term.
Recommendations; registered patients and caregivers.
The bill authorizes physicians, physician assistants, and certified advanced practice nurse prescribers to provide a written recommendation for a patient to use medical marijuana under certain circumstances, including the existence of a bonafide health care provider-patient relationship and that the patient suffers from qualifying medical condition. Minors are eligible to receive a recommendation for use of medical marijuana if certain requirements are met. Medical marijuana must be in the form of a liquid, oil, pill, or tincture or in a form that is applied topically.
Under the bill, patients and primary caregivers may apply to the commission to receive a registry identification card, allowing the patient or primary caregiver to obtain medical marijuana from a dispensary. Applicants must meet certain criteria, including that the person is a resident of the state and submits a written recommendation that is less than 30 days old from a physician, physician assistant, or certified advanced practice nurse prescriber.
A primary caregiver must be over the age of 21 and may not have any drug-related conviction. The commission is required to establish and maintain a list of registered cardholders and must establish rules for implementation of the medical marijuana program as it relates to recommendation and registration.
The bill also requires the commission to establish procedures for physicians, physician assistants, and certified advanced practice nurse prescribers to apply for certification and to be certified to recommend the use of medical marijuana to qualifying patients. All such persons certified by the commission must keep complete and accurate records of the recommendations made and for whom the recommendations are made and provide that information to the commission at the commission's request.
The bill provides civil, criminal, and professional disciplinary immunity for physicians, physician assistants, and certified advanced practice nurse prescribers who recommend medical marijuana for patients in accordance with the requirements and limitations specified in the bill.
However, the bill allows the Medical Examining Board and the Board of Nursing to issue non mandatory guidelines regarding best practices in making recommendations for the use of medical marijuana.
Licensed producers, processors, transporters, dispensaries, and laboratories
The bill requires any person operating as a medical marijuana producer, processor, transporter, dispensary, or laboratory to obtain a license from the commission. An applicant may not obtain a license if the applicant, or any principal officer or board member, has been convicted of a controlled substance offense. The applicant, and each principal officer or board member, must be at least 21 years old, and may not have been a principal officer or board member of a producer, processor, transporter, dispensary, or laboratory that has had its license revoked and not reinstated. In addition, the applicant or at least one principal officer or board member must be a resident of this state. The applicant must also show that it will have sufficient security measures and record-keeping procedures in place. A producer, processor, or dispensary may not have any financial interest in a laboratory, and a laboratory may not have any financial interest in a producer, processor, or dispensary. A license issued by the commission expires after one year.
Under the bill, a licensee may not operate within 300 feet of a school or child care center. Every employee of a licensee must be at least 21 years old and may not have been convicted of a controlled substance offense. In addition, dispensary employees must complete certain training, as required by the commission by rule.
The bill requires licensed producers, licensed processors, and licensed laboratories to operate within an enclosed, locked facility. A licensed producer is prohibited from growing medical marijuana for personal, family, or household use and may distribute its medical marijuana only to a licensed processor. A licensed processor must send samples of the medical marijuana that it processes to a licensed laboratory to test and certify the tetrahydrocannabinol (THC) concentration of the processor's products and test for the presence of certain contaminants; must package its products in child-resistant packaging; and must label each package with how many ounces of medical marijuana it contains and the THC concentration of the product. A licensed processor may distribute its products only to a licensed dispensary. A licensed dispensary must label the medical marijuana that it dispenses with certain information, including the name of the dispensary and the name of the patient, and may dispense medical marijuana only to a person who presents a valid registry identification card and only in accordance with the patient's recommendation. All marijuana and medical marijuana that is transported by way of a public road may only be transported by a licensed transporter.
The bill also authorizes the commission to inspect, without prior notice, the premises and records of a licensee or an applicant. The commission may also establish rules for suspending, revoking, or refusing to issue or renew a license. The bill authorizes the commission to promulgate any other rules necessary to administer and implement the medical marijuana program as it relates to producers, processors, transporters, dispensaries, and laboratories.
Medical marijuana tax
The bill imposes an excise tax on a licensed processor at the rate of 10 percent of the sales price on each wholesale sale in this state of marijuana to a licensed dispensary. All proceeds from the tax, and all fees and penalties collected by the commission, are deposited into a segregated fund, identified in the bill as the medical marijuana fund.
The bill decriminalizes the manufacture, possession, distribution, and delivery of medical marijuana if that manufacture, possession, distribution, or delivery is done in compliance with the medical marijuana program established by the commission.
Under current law, with certain exceptions, it is illegal to manufacture, possess, distribute, or deliver THC, including THC in marijuana, which is classified as a schedule I controlled substance. The bill authorizes the possession, distribution, or delivery of medical marijuana by a qualifying patient or his or her primary caregivers if 1) the possession, distribution, or delivery of marijuana is done to facilitate a qualifying patient's medical use of the marijuana in accordance with his or her recommendation; 2) the marijuana is legally obtained from a person who is authorized to distribute or deliver medical marijuana under the laws of this state; 3) the amount of usable marijuana does not exceed 15 grams of cannabis concentrate per qualifying patient; and 4) the qualifying patient or primary caregiver has in his or her immediate possession a registry identification card. The bill authorizes the manufacture, possession, distribution, or delivery of medical marijuana by an entity that is licensed by the commission or an employee or agent of such a licensed entity if the manufacture, possession, distribution, or delivery is done in the usual course of business or employment.
Under the bill, if a person manufactures, possesses, distributes, delivers, or uses medical marijuana in a way that is not in compliance with the requirements of the medical marijuana program, he or she can be referred by the Medical Marijuana Regulatory Commission for criminal prosecution under the controlled substances act or a local law that prohibits the possession, manufacture, distribution, or delivery of marijuana.
Prescription drug monitoring program
Current law requires the Controlled Substances Board to establish a Prescription Drug Monitoring Program (PDMP) that requires pharmacies and health care practitioners to generate records documenting the dispensing of monitored prescription drugs. Records from the PDMP may be disclosed to persons specified under current law or by the board by rule.
This bill also requires records to be generated for the PDMP documenting recommendations for medical marijuana and the issuance of registry identification cards for medical marijuana.
Fair employment law
Under the current fair employment law, an employer may not refuse to hire or employ, bar or terminate from employment, or discriminate against any individual in promotion or compensation or in terms, conditions, or privileges of employment because the individual has a disability. Such discrimination against an individual with a disability includes refusing to reasonably accommodate an employee's or prospective employee's disability unless the employer can demonstrate that the accommodation would pose a hardship on the employer's program, enterprise, or business. Also under the fair employment law, an employer may not refuse to hire or employ, bar or terminate from employment, or discriminate against any individual in promotion or compensation or in terms, conditions, or privileges of employment because of the individual's use or nonuse of lawful products off the employer's premises during nonworking hours.
DWD enforces the fair employment law and may receive and investigate complaints charging discrimination or discriminatory practices and may, if an employer is found to have engaged in discrimination, order such action by the respondent as will effectuate the purpose of the fair employment law, including awarding back pay. Decisions of DWD hearing examiners made under the fair employment law are subject to further review by the Labor and Industry Review Commission and a court.
The bill provides that the fair employment law does not apply to any act of an employer based on an individual's use of medical marijuana. Unemployment insurance; worker's compensation
Currently, an individual whose work is terminated by an employer for misconduct by the employee connected with the employee's work is ineligible to receive unemployment insurance benefits until the individual satisfies certain conditions. In addition, the wages paid to the individual by that employer are excluded from the employee's base period wages for purposes of calculating the individual's entitlement to UI benefits. "Misconduct," for purposes of these provisions, is defined specifically as including a violation by an employee of an employer's reasonable written policy concerning the use of a controlled substance if the employee 1) had knowledge of the policy; and 2) admitted to the use of a controlled substance or refused to take a test or tested positive for the use of a controlled substance in a test used by the employer in accordance with a testing methodology approved by DWD.
Also under current law, an employer is not liable for temporary disability benefits under the worker's compensation law during an employee's healing period if the employee is suspended or terminated for misconduct as defined above. The bill retains these provisions regarding misconduct and further provides that such a reasonable written policy may include a drug-free workplace policy.
Because this bill creates a new crime or revises a penalty for an existing crime, the Joint Review Committee on Criminal Penalties may be requested to prepare a report.